FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3016857003> ?p ?o ?g. }

• W3016857003 endingPage "1387" @default.
• W3016857003 startingPage "1377" @default.
• W3016857003 abstract "Objective To evaluate whether there is an increased risk of neurologic diagnoses in children who are HIV-exposed but uninfected (CHEU) exposed in utero to specific antiretroviral medications. Design Prospective cohort study of CHEU enrolled from 2007 to 2017. Methods We evaluated children for neurologic case status, including microcephaly, febrile seizures, seizure disorders, ophthalmologic disorders, and other neurologic disorders. Adjusted relative risks (aRRs) were estimated for the association between in-utero antiretroviral exposure and neurologic case using log-binomial regression, accounting for potential confounders. Sensitivity analyses were conducted to evaluate robustness of findings. Results Among 3747 eligible CHEU, 231 (6.2%) met neurologic case criteria (95% CI 5.4--7%). Most eligible children (86%) were exposed in utero to combination antiretroviral regimens. In adjusted models, children exposed to efavirenz at any time during pregnancy had higher risk of neurologic case status (aRR = 1.53, 95% CI 0.94--2.51). This association was stronger when comparing efavirenz exposure at conception to no exposure during pregnancy (aRR = 1.92, 95% CI 1.09--3.36) and considering follow-up and case diagnosis only through age 2 (aRR = 2.14, 95% CI 1.11--4.12). Children exposed to didanosine at conception and during the first trimester had increased risk of neurologic case status (aRR = 2.28, 95% CI 1.07--4.87 and aRR = 2.02, 95% CI 1.01--4.04, respectively), compared with didanosine-unexposed children. Children with dolutegravir exposure had some suggestion of increased risk of neurologic case (aRR = 2.43, 95% CI 0.75--7.84), which was observed consistently across several sensitivity analyses. Conclusion Efavirenz and didanosine exposure during pregnancy were associated with higher risk of neurologic abnormalities in CHEU, and dolutegravir exposure showed some suggestive associations, which warrant further monitoring." @default.
• W3016857003 created "2020-04-24" @default.
• W3016857003 creator A5012727515 @default.
• W3016857003 creator A5029314880 @default.
• W3016857003 creator A5039626893 @default.
• W3016857003 creator A5043215854 @default.
• W3016857003 creator A5055628988 @default.
• W3016857003 creator A5069096618 @default.
• W3016857003 creator A5070687411 @default.
• W3016857003 creator A5074286173 @default.
• W3016857003 creator A5080752098 @default.
• W3016857003 date "2020-04-16" @default.
• W3016857003 modified "2023-10-05" @default.
• W3016857003 title "Safety of in-utero antiretroviral exposure: neurologic outcomes in children who are HIV-exposed but uninfected" @default.
• W3016857003 cites W1946352393 @default.
• W3016857003 cites W1995685243 @default.
• W3016857003 cites W1995798071 @default.
• W3016857003 cites W2011188155 @default.
• W3016857003 cites W2017519401 @default.
• W3016857003 cites W2021912735 @default.
• W3016857003 cites W2026172693 @default.
• W3016857003 cites W2030243175 @default.
• W3016857003 cites W2060235433 @default.
• W3016857003 cites W2061082458 @default.
• W3016857003 cites W2061549298 @default.
• W3016857003 cites W2075856485 @default.
• W3016857003 cites W2077387106 @default.
• W3016857003 cites W2085560533 @default.
• W3016857003 cites W2111112758 @default.
• W3016857003 cites W2112669742 @default.
• W3016857003 cites W2131329205 @default.
• W3016857003 cites W2137523151 @default.
• W3016857003 cites W2262700604 @default.
• W3016857003 cites W2312347679 @default.
• W3016857003 cites W2343795686 @default.
• W3016857003 cites W2443605059 @default.
• W3016857003 cites W2606421020 @default.
• W3016857003 cites W2679757027 @default.
• W3016857003 cites W2810862601 @default.
• W3016857003 cites W2883284210 @default.
• W3016857003 cites W2883351527 @default.
• W3016857003 cites W2913511733 @default.
• W3016857003 cites W2929154458 @default.
• W3016857003 cites W2933955404 @default.
• W3016857003 cites W2963164305 @default.
• W3016857003 cites W2963200087 @default.
• W3016857003 doi "https://doi.org/10.1097/qad.0000000000002550" @default.
• W3016857003 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8136420" @default.
• W3016857003 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32310900" @default.
• W3016857003 hasPublicationYear "2020" @default.
• W3016857003 type Work @default.
• W3016857003 sameAs 3016857003 @default.
• W3016857003 citedByCount "17" @default.
• W3016857003 countsByYear W30168570032020 @default.
• W3016857003 countsByYear W30168570032021 @default.
• W3016857003 countsByYear W30168570032022 @default.
• W3016857003 countsByYear W30168570032023 @default.
• W3016857003 crossrefType "journal-article" @default.
• W3016857003 hasAuthorship W3016857003A5012727515 @default.
• W3016857003 hasAuthorship W3016857003A5029314880 @default.
• W3016857003 hasAuthorship W3016857003A5039626893 @default.
• W3016857003 hasAuthorship W3016857003A5043215854 @default.
• W3016857003 hasAuthorship W3016857003A5055628988 @default.
• W3016857003 hasAuthorship W3016857003A5069096618 @default.
• W3016857003 hasAuthorship W3016857003A5070687411 @default.
• W3016857003 hasAuthorship W3016857003A5074286173 @default.
• W3016857003 hasAuthorship W3016857003A5080752098 @default.
• W3016857003 hasBestOaLocation W30168570032 @default.
• W3016857003 hasConcept C142462285 @default.
• W3016857003 hasConcept C172680121 @default.
• W3016857003 hasConcept C187212893 @default.
• W3016857003 hasConcept C201614185 @default.
• W3016857003 hasConcept C203014093 @default.
• W3016857003 hasConcept C2776452011 @default.
• W3016857003 hasConcept C2779234561 @default.
• W3016857003 hasConcept C2779690655 @default.
• W3016857003 hasConcept C2780727368 @default.
• W3016857003 hasConcept C2993143319 @default.
• W3016857003 hasConcept C3013748606 @default.
• W3016857003 hasConcept C3018457394 @default.
• W3016857003 hasConcept C54355233 @default.
• W3016857003 hasConcept C71924100 @default.
• W3016857003 hasConcept C86803240 @default.
• W3016857003 hasConceptScore W3016857003C142462285 @default.
• W3016857003 hasConceptScore W3016857003C172680121 @default.
• W3016857003 hasConceptScore W3016857003C187212893 @default.
• W3016857003 hasConceptScore W3016857003C201614185 @default.
• W3016857003 hasConceptScore W3016857003C203014093 @default.
• W3016857003 hasConceptScore W3016857003C2776452011 @default.
• W3016857003 hasConceptScore W3016857003C2779234561 @default.
• W3016857003 hasConceptScore W3016857003C2779690655 @default.
• W3016857003 hasConceptScore W3016857003C2780727368 @default.
• W3016857003 hasConceptScore W3016857003C2993143319 @default.
• W3016857003 hasConceptScore W3016857003C3013748606 @default.
• W3016857003 hasConceptScore W3016857003C3018457394 @default.
• W3016857003 hasConceptScore W3016857003C54355233 @default.
• W3016857003 hasConceptScore W3016857003C71924100 @default.
• W3016857003 hasConceptScore W3016857003C86803240 @default.

• next